The Threshold for Fraud and Criminal Behavior

The speakers discuss the intentional misrepresentation by a company about the addictive nature of their product and whether it constitutes criminal fraud. They delve into the responsibility of the federal government and the FDA in the opioid crisis and raise questions about withholding information and its implications for fraud. The chapter also explores the concept of corporate liability and the protections provided by corporations, as well as the controversy surrounding bankruptcy settlements.